Why can't I audit Ironsail Pharma pricing line by line?

The pricing transparency problem shows up at the worst moment: a patient is in front of you ready to start semaglutide or tirzepatide, and you cannot tell them the cost because your platform does not show landed per-vial pricing. You either guess, quote a padded number to be safe, or tell the patient you will follow up — and follow-ups are where conversions go to die.

For owners, the same opacity makes margin planning a moving target. If the cost per vial is only knowable after a quote and can shift with volume tiers, building a predictable cash-pay program means working from estimates rather than numbers. The delay is not just minutes; it is the inability to make confident pricing decisions.

Ironsail Pharma advertises cross-pharmacy price comparison, a Price Match Guarantee, and 42% average cost savings across its 20+ pharmacy network as of June 2026. Those are useful for choosing among marketplace options, but they are not the same as resolved per-vial 503A cost with a disclosed facilitation fee on every catalog and cart line. A network-wide savings statistic cannot answer what this specific vial costs for margin planning or patient quoting.

When you evaluate this model, the right questions are about auditability: whether per-vial landed cost appears on each line before checkout, whether the facilitation or platform fee is disclosed separately from drug price, and whether you can compare your top five SKUs against another vendor without signing up first. If pricing only surfaces as relative comparison inside ImpetusRX after onboarding, the transparency gap repeats every time you evaluate a new SKU or partner.

The delay disappears when pricing is visible at the point of decision. Fizy Health shows resolved per-vial 503A cost on each catalog and cart line before checkout, with the facilitation fee disclosed at payment, so a clinician can quote a patient in the room and an owner can model margin from real numbers. There is no sales gate between you and the cost of the medication you are about to order.

Pass-through pricing is the structural difference: instead of a negotiated rate hidden in a quote, you see the 503A cost and the disclosed fee. The evaluation test is whether you can answer what does this vial cost without sending an email. When the catalog answers that question, the consult keeps moving and pricing stops being a bottleneck.